Cranial computed tomography interpretation in acute stroke: Physician accuracy in determining eligibility for thrombolytic therapy

JAMA

Volumn 279, Issue 16, 1998, Pages 1293-1297

  Schriger, David L ^a,f   Kalafut, Mary ^a   Starkman, Sidney ^a,b,c,d   Krueger, Michelle ^a   Saver, Jeffrey L ^a,b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^d Stroke Speakers' Bureau

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN CALCIFICATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FIBRINOLYTIC THERAPY; HUMAN; HUMAN EXPERIMENT; MEDICAL SPECIALIST; PRIORITY JOURNAL; RADIOLOGIST; STROKE;

EID: 0032557132     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.16.1293     Document Type: Article

References (18)

1. Nightingale SL. t-PA approved for acute ischemic stroke [From the Food and Drug Administration]. JAMA. 1996;276:443.
2. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Multicenter Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
4. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
5. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA. 1996;276: 961-966.
6. Multicenter Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335: 145-150.
7. Special Writing Committee of the Stroke Council, American Heart Association. Guidelines for thrombolytic therapy for acute stroke. Stroke. 1996; 27:1711-1718.
8. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke: summary statement. Neurology. 1996;47:835-839.
9. National Stroke Association consensus statement: stroke: the first hours: emergency evaluation and treatment guidelines. In: Stroke Clinical Updates. Englewood, Colo: National Stroke Association; 1997.
10. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
11. Moulin T, Besson G, Crepin-Leblond T, et al. Hemorrhagic transformations in MAST-E trial: predictive factors [abstract]. Cerebrovascular Dis. 1996;6:182.
12. Larrue V, von Kummar R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997;28:957-60.
13. Ebel RL, Frisbie DA. Essentials of Educational Measurement. 4th ed. Englewood Cliffs, NJ: Prentice-Hall International Inc; 1986:335-339.
14. Wainer H, Dorans NJ, Flangher R, et al. Computerized Adaptive Testing: A Primer. Hillsdale, NJ: Lawrence Erlbaum Associates Inc Publishers; 1990.
15. Stata Corporation. Stata 5.0 Statistical Software User's Guide. College Station, Tex: Stata Corp; 1997:235-239.
16. Sacco R. Classification of stroke. In: Fisher M, ed. Clinical Atlas of Cerebrovascular Disorders. London, England: Mosby-Year Book Inc; 1994:2.1-2.23.
17. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997;205:327-333.
18. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Generalized efficacy t-PA for acute stroke: subgroup analysis of the NINDS stroke trial. Stroke. 1997; 28:2119-2125.